Showing: 1 - 4 of 4 RESULTS

Trump suggests he may hold weekend rallies in Florida, Pennsylvania after receiving green light from doctor

President Trump told Fox News’ Sean Hannity in an exclusive interview Thursday that his campaign is trying to make last-minute arrangements for holding weekend rallies in Florida and Pennsylvania after White House physician Dr. Sean Conley cleared him for public engagements earlier in the day.

“I think I’m going to try doing a rally on Saturday night if we have enough time to put it together,” Trump said on “Hannity”.


“We want to do a rally probably in Florida on Saturday night. I might come back and do one in Pennsylvania the following night,” he said, adding that “it’s incredible what’s going on. I feel so good.”

Dr. Conley sent out a memorandum Thursday evening stating that Trump will be able to return to public engagements this weekend, noting that Saturday will mark ten days since he was first diagnosed with the coronavirus.

Conely’s memo stated that Trump has responded “extremely well to treatment” and added there is no sign of “adverse therapeutic effects.”

The Centers for Disease Control and Prevention (CDC) says people “with mild to moderate COVID-19 remain infectious no longer than 10 days after symptom onset. People with more severe symptoms can remain infectious for longer.”


Trump said he will “probably” take a test on Friday to be sure of a negative result, but claimed his doctors “found very little infection or virus, if any,” in a previous unspecified test.

“I don’t know if they found any,” he said. “I didn’t go into it greatly with the doctors. We have these great doctors at Walter Reed, and you do rely on them, they are really fantastic talents and they came in from Johns Hopkins also and other places.


Trump said he was being closely monitored, telling Hannity that he “never saw so many doctors looking over me.

“I think I’m the most analyzed human being in the world right now,” he said.

Source Article

Research gives green light for migraine relief

A pilot study suggests that exposure to green light of a particular wavelength and brightness may be as effective as drugs in reducing the frequency and severity of migraine.

According to the Migraine Research Foundation, about 12% of people in the United States experience migraine.

The condition involves moderate-to-severe headaches, which often accompany debilitating symptoms, such as visual disturbances, nausea, vomiting, dizziness, and extreme sensitivity to sound and light.

Affected individuals frequently report having a lower quality of life and needing to take time off work as a result of their condition. Research suggests that they are more likely to use and overuse pain relief medications, including opioids.

Some people do not get adequate pain control from drugs or experience unpleasant side effects when they take them. Finding alternative therapies to replace or complement these treatments is, therefore, a priority.

One possibility is light therapy. Previous research by doctors at the University of Arizona College of Medicine in Tucson found that green light had pain-relieving effects in rats.

The same team has now conducted the first clinical study of green light as a preventive therapy for migraine, with promising results.

“As a physician, this is really exciting,” says lead author Dr. Mohab Ibrahim, an associate professor at the college and director of its Chronic Pain Management Clinic. “Now, I have another tool in my toolbox to treat one of the most difficult neurological conditions — migraine.”

The researchers report their study in Cephalalgia, the journal of the International Headache Society.

The researchers recruited 29 people, seven of whom had episodic migraine (defined as up to 14 headache days per month), while 22 had chronic migraine (15 or more headache days per month for 3 or more months). All of the participants were unsatisfied with their current treatment.

Initially, for 10 weeks, the participants spent 1–2 hours daily at home in an otherwise dark room lit by a white LED (light-emitting diode) strip. The white lighting served as a control condition.

A “washout period” of 2 weeks without any light treatment followed.

Finally, for a further 10 weeks, all 29 individuals spent 1–2 hours daily with an LED strip emitting green light with a wavelength of about 525 nanometers and the same brightness as the white light.

The researchers encouraged the participants to stay awake during the light treatment and do things that required no additional lighting, such as reading a book, listening to music, or doing exercise.

Throughout the study, each participant filled out questionnaires reporting the number of headaches that they experienced and their intensity. In addition, they answered questions relating to quality of life, such as their ability to work and to fall and stay asleep.

Overall, the green light treatment was associated with a significant decrease in the frequency of headaches, from an average of 18.4 days per month before the treatment to 7.4 days per month afterward (a reduction of about 60%).

Among those with episodic migraine, the number of headache days per month declined

15-minute coronavirus test gets the green light for a European rollout

Dr. Vincent Carrao draws blood from a patient for the coronavirus disease (COVID-19) test at Palisades Oral Surgery, in Fort Lee, New Jersey, U.S., June 15, 2020. Picture taken June 15, 2020.

Brendan McDermid | Reuters

A test to detect Covid-19 that can be done at the point of care and gives results in 15 minutes has been given the greenlight in Europe, according to its maker Becton Dickinson.

The test should be commercially available in Europe by the end of October, the diagnostics specialist said Wednesday, as it announced its antigen test had been granted a “CE mark” in Europe, meaning it conforms with health, safety, and environmental protection standards for products sold within the region.

The new test delivers results in 15 minutes on a small, portable instrument, BD said in a statement Wednesday, adding that this is a “critical improvement in turnaround time for Covid-19 diagnostics, because it provides real-time results and enables decision-making while the patient is still onsite.”

“The addition of a truly portable, point-of-care test that can deliver results while the patient waits will be welcomed by health care providers and patients alike to help protect against additional waves of Covid-19,” Roland Goette, president of BD EMEA, remarked. 

In July, the U.S. Food and Drug Administration (FDA) granted emergency use authorization to the company’s rapid antigen test, that works by looking for proteins that can be found on or inside the Covid-19 virus.

It has been widely reported that while antigen tests can be carried out faster than molecular diagnostic tests which are conducted in laboratories, they are generally less accurate.

Becton Dickinson says that clinical studies performed at more than 20 sites across the U.S. demonstrated that the test is capable of achieving 84% sensitivity (a measure of how well it correctly identifies infections) and 100% specificity (how well it correctly identifies negative tests) but the U.S. FDA recommends that negative test results be confirmed by a molecular method to confirm the result.

BD said it is leveraging its global manufacturing network and scale to produce 8 million Covid-19 antigen tests per month by October and expects to produce 12 million tests per month by March 2021.

It is by no means alone in developing a rapid antigen test for the virus, with Roche announcing earlier in September that its own 15-minute antigen test had received the CE mark and German diagnostic test maker Qiagen also announcing earlier this month that it planned to launch a 15-minute antigen test.

In mid-September it was reported that BD was looking into reports from nursing homes that its rapid Covid-19 testing equipment was producing false positive results in some cases.

Source Article

Reflection And Refraction Of Light & It is Applications

Greater than half of all people have ever experienced infected gums. Ultimately, you need to find a dentist that may work with you to be able to get the appropriate dental care, and their billing insurance policies should be clear and simple. These methods are permitting dentists to be way more environment friendly with their affected person recall and patient scheduling.

One other toothpaste suggestion since the Crest 3D might have brought on your gums to recede is Crest Professional Health for Gums. Esthetic dentistry caters to many individuals both for necessity or for enhancing their smile. If you happen to smoke, the immune system in your mouth weakens, so you’ll be able to easily get inflamed gums.

Watch out for mouthwashes include alcohol, these can make gums irritating and will not be really useful to share with youngsters. Aside from diagnosing, treating and preventing illnesses that have an effect on the teeth, the general dentist also provides dependable information to patients.

I might recommend if anybody (or cherished one) is on treatment, has an sickness, or uncomfortable side effects from treatment that causes dry mouth – work along with your physician and dentist to manage it – as lengthy-time period effects from dry mouth can cause you to lose your tooth.

Why dentists take such a relatively long time in injecting you. Sometimes this third molar, or wisdom tooth, might by no means come out in any respect, and when it does come, it often does not come down to a stage with the other teeth. 5. Oral Prophylaxis – such a dental service entails tooth sprucing and scaling.…